Journal of Ophthalmology / 2019 / Article / Tab 1

Research Article

Trabeculectomy and EX-PRESS Implantation in Open-Angle Glaucoma: An Updated Meta-Analysis of Randomized Controlled Trials

Table 1

Characteristics of the included randomized clinical trials.

First author (year)LocationNo. of eyes (EX/Tr)Type of glaucomaAntimetabolityFollow-up (m)

Errico (2016) [6]Italy16/10Secondary OAGMitomycin-C 0.1 mg/mL, 5 minutes24
Netland (2014) [8]USA59/61POAG, PXFG, PGMitomycin-C 0.25 mg/mL, 1-2 minutes24
Gonzalez–Rodriguez (2016) [9]Canada32/31OAGMitomycin-C 0.4 mg/mL, 2 minutes36
El-Saied (2017) [10]Egypt10/10Secondary OAGMitomycin-C 0.4 mg/mL, 2 minutes12
Dahan (2012) [11]Israel15/15POAGMitomycin-C 0.05%, 1 minute30
de Jong (2011) [12]France39/39POAG, PXFG, PGMitomycin-C 0.02%60
Arimura (2018) [13]Japan32/32POAG, XFGMitomycin-C 0.4 mg/mL, 4 minutes24
Mendoza–Mendieta (2016) [14]Mexico20/19POAG, PXFG, PG, steroid-induced, traumaticMitomycin-C19

EX: EX-PRESS; Tr: trabeculectomy; POAG: primary open-angle glaucoma; PXFG: pseudoexfoliation glaucoma; PG: pigmentary glaucoma; MMC: mitomycin-C; min: minute; m: month.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.